11.03.2010 • Product

AvaSpire PEEK-Based Plastic Products

Modified PEEK Resin Based Stock Shape Products Enable Manufacturers in Health Care, Transportation, Electronics and Chemical Processing Industries to Meet Demanding Applications at a Lower Price Point.

Quantum Polymers announced the availability of extruded stock shape plastic products made with AvaSpire resin from Solvay Advanced Polymers (Alpharetta, Ga.). AvaSpire is a modified polyetheretherketone (PEEK) resin that has been formulated to offer improved ductility, mechanical strength and higher operating temperature relative to PEEK while retaining most of the key performance attributes of PEEK at a lower price point.

Quantum Polymers is offering AvaSpire PEEK extruded rods and plates. Rods are available from 3/8" to 4" diameter whereas plates are available from 3/8" to 3" thickness. AvaSpire works well for applications requiring a balance of chemical resistance and mechanical strength. As such, Quantum is offering this material well suited for price sensitive applications in healthcare, transportation, electronics, chemical processing and other areas of manufacturing.

AvaSpire PEEK is U.S. FDA compliant for food and healthcare products. It also meets ISO 10993 specifications for medical devices.

"We are pleased to announce the incorporation of AvaSpire as the newest member in our PEEK offerings," said Hemant Bheda, CEO of Quantum Polymers. "Using AvaSpire will help us achieve our value proposition objectives, in terms of offering our customers wider product choice at various price and performance points for demanding applications."

"Working with Quantum Polymers allows us to offer AvaSpire modified PEEK in a broader range of options than ever before and we're excited to have this new level of performance available to our customers," said Jean-Baptiste Bonnadier, Ultra Polymers Product Manager for Solvay Advanced Polymers.

 

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

29 April 2026 | This webinar explores how chemical industry organizations can design a digital‑ and AI‑ready operating model focused on clarity, usability, and measurable value.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read